Home > Insider Trading > Filing (0001127602-24-005831)

Filing Details

Accession Number:: 0001127602-24-005831
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-20 17:32:42
Reporting Period:: 2024-02-15

Accepted Time:: 2024-02-20 17:32:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100682	Charles River Laboratories International Inc.	CRL	Services-Commercial Physical & Biological Research (8731)	061397316

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1952784	M Shannon Parisotto	251 Ballardvale Street Wilmington MA 01887	Cevp, Disc & Safety Assessment	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-02-15	291	$237.20	8,187	No	4	S	Direct
Common Stock	Disposition	2024-02-15	1,290	$239.28	6,897	No	4	S	Direct
Common Stock	Disposition	2024-02-15	1,617	$240.12	5,280	No	4	S	Direct
Common Stock	Disposition	2024-02-15	610	$241.28	4,670	No	4	S	Direct
Common Stock	Disposition	2024-02-15	632	$242.43	4,038	No	4	S	Direct
Common Stock	Disposition	2024-02-15	604	$243.96	3,434	No	4	S	Direct
Common Stock	Disposition	2024-02-15	749	$244.61	2,685	No	4	S	Direct
Common Stock	Disposition	2024-02-15	89	$245.34	2,596	No	4	S	Direct
Common Stock	Acquisiton	2024-02-15	5,882	$144.67	8,478	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2024-02-15	5,882	$0.00	5,882	$144.67

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-02-22	2024-02-22	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	29,406	Indirect	by Karpathos Investments LLC

Footnotes

Reflects the exempt transfer pursuant to Rule 16a-13 of 370 shares held by the reporting person to Karpathos Investments LLC.
This transaction was executed in multiple trades at prices ranging from $236.71 to $237.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
This transaction was executed in multiple trades at prices ranging from $238.73 to $239.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
This transaction was executed in multiple trades at prices ranging from $239.76 to $240.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
This transaction was executed in multiple trades at prices ranging from $240.83 to $241.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
This transaction was executed in multiple trades at prices ranging from $241.97 to $242.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
This transaction was executed in multiple trades at prices ranging from $243.26 to $244.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
This transaction was executed in multiple trades at prices ranging from $244.27 to $45.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.